-
Get the latest information and research on osteoporosis.
-
Find treatment, guidance and advice on living with osteoporosis.
-
Share your experience and get involved. Joining the conversation is the first step to ending osteoporosis and broken bones.
NOF in the News
Advances in Osteoporosis Prevention, Diagnosis and Treatment Presented at 8th International Symposium of National Osteoporosis Foundation
NOF in the News
NOF
Washington, DC
April 1, 2009
Washington, DC (April 1, 2009) – A faculty of internationally-renowned osteoporosis experts are gathering today to share the latest clinically-relevant information on osteoporosis prevention, diagnosis and treatment at the National Osteoporosis Foundation’s (NOF) 8th International Symposium on Osteoporosis (ISO8): “Translating Research Into Clinical Practice,” April 1-5, 2009 at the Marriott Wardman Park Hotel in Washington, DC Held once every two years, ISO8 aims to bridge the gap between osteoporosis research and its application in clini
National Osteoporosis Foundation's 8th International Symposium April 1-5, 2009 at Marriott Wardman Park Hotel
NOF in the News
NOF
Washington, DC
March 19, 2009
Washington, DC (March 19, 2009) – The National Osteoporosis Foundation (NOF) will bring together a faculty of internationally-renowned experts to share clinically relevant evidence-based information on bone health and osteoporosis prevention, diagnosis and treatment with hundreds of healthcare professionals at its comprehensive annual five-day conference in Washington, DC.
NOF
Washington, DC
March 16, 2009
Washington, DC (March 16, 2009) – Osteoporosis is a serious, widespread and growing public health threat, according to the National Osteoporosis Foundation (NOF). NOF welcomes any new FDA approved treatment options that will help patients address this prevalent disease, such as once-yearly Reclast® approved to treat and prevent steroid-induced osteoporosis, its fourth approved indication from the FDA. NOF estimates 10 million Americans age 50 and older have osteoporosis and another 34 million are at risk for the disease.
###
New Resource Focuses on the Growing Burden of Osteoporosis and Value of Medical Innovation
NOF in the News
NOF
Washington, DC
July 31, 2008
Washington, DC (July 31, 2008) – Today the Alliance for Aging Research, in partnership with the National Osteoporosis Foundation (NOF), released a new volume of The Silver Book®: Chronic Disease and Medical Innovation in an Aging Nation. The latest addition to The Silver Book series focuses on the most prevalent bone disease in the U.S.—osteoporosis. The volume was released at a Capitol Hill briefing which featured medical and economic experts and patients. In addition, Reps.
NOF
July 24, 2008
Washington, DC (July 24, 2008) – The National Osteoporosis Foundation (NOF) mourns the passing of Pierre D. Delmas, M.D., Ph.D. of Lyon, France. Prof. Delmas was an internationally recognized expert in the areas of osteoporosis and metabolic bone disease. He authored more than 400 articles, reviews and chapters in international scientific journals and textbooks. Dr. Delmas served as founding president of the International Osteoporosis Foundation (IOF), for which he initiated numerous global educational, clinical and research programs on osteoporosis.
Summit for National Action Plan for Bone Health Convened by Leading Bone Organizations
NOF in the News
NOF
June 25, 2008
Washington, DC (June 25, 2008) – The National Osteoporosis Foundation (NOF) will host an unprecedented summit to develop a coordinated national action plan to promote bone health on June 26 – 27, 2008 in Washington, DC.
Key Stakeholders Join Effort to Increase Awareness Among the Public and Health Professionals on the Prevention, Diagnosis and Treatment of Osteoporosis and Related Bone Diseases
U.S. House of Representatives Approves the "Mother's Day Centennial Commemorative Coin Act" to Support Osteoporosis Research
NOF in the News
NOF
June 11, 2008
Washington, DC (June 11, 2008) – The U.S. House of Representatives voted to pass the “Mother’s Day Centennial Commemorative Coin Act” (HR 2268), which, if passed by the Senate and signed into law by the President, authorizes the U.S. Mint to produce a commemorative coin in 2014 in honor of the centennial of the holiday Mother’s Day. Each coin will carry a $10.00 surcharge that would be divided evenly between the National Osteoporosis Foundation (NOF) and the Susan G. Komen for the Cure to further their research grant programs.
Following is a Statement by the National Osteoporosis Foundation on the U.S. Food and Drug Administration’s Approval of Once-a-Month ACTONEL ®
NOF in the News
NOF
Washington, DC
June 10, 2008
Washington, DC (June 10, 2008)– Osteoporosis is a serious, widespread and growing public health threat, according to the National Osteoporosis Foundation (NOF). NOF welcomes any new FDA approved treatment options, such as Once-a-Month ACTONEL®, that will help patients address this prevalent disease. NOF estimates 10 million Americans age 50 and older have osteoporosis and another 34 million are at risk for the disease.
###
National Osteoporosis Foundation Survey Reveals Low Awareness of Bone Health and Risk of Osteoporosis
NOF in the News
NOF
Washington, DC
May 22, 2008
Washington, DC (May 22, 2008) – The National Osteoporosis Foundation (NOF) today announced results of a nationwide survey that reveals a concerning low awareness of bone health and risk for osteoporosis in American men and women age 45 and older, as well as a lack of conversations regarding bone health between patients in this age group and their health professionals.
NOF
Washington, DC
May 15, 2008
Washington, DC (May 15, 2008) – The National Osteoporosis Foundation (NOF) will launch a prestigious recognition event, Legends of Osteoporosis Lecture, on Friday, May 16, 2008, to honor prominent researchers in the area of osteoporosis.
